AustralieFrV1, PascalFrancis, Curation, bibRecord, 005756

The Value of and Challenges for Cholera Vaccines in Africa

Identifieur interne : 005756 ( PascalFrancis/Curation ); précédent : 005755; suivant : 005757

The Value of and Challenges for Cholera Vaccines in Africa

Auteurs : Lorenz Von Seidlein [Australie] ; Mohammad Jiddawi [Tanzanie] ; Rebecca F. Grais [France] ; Francisco Luquero [France] ; Marcelino Lucas [Mozambique] ; Jacqueline Deen [Australie]

Source :

The Journal of infectious diseases [ 0022-1899 ] ; 2013.

RBID : Pascal:13-0348253

Descripteurs français

Pascal (Inist)
- Vibrio cholerae, Vaccin, Afrique, Infection.
Wicri :
- topic : Vaccin.

English descriptors

KwdEn :
- Africa, Infection, Vaccine, Vibrio cholerae.

Abstract

The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.

A01	`01`	`1`		`@0 0022-1899`
A02	`01`			`@0 JIDIAQ`
A03		`1`		`@0 J. infect. dis.`
A05				`@2 208`
A06				`@3 SUP1`
A08	`01`	`1`	`ENG`	`@1 The Value of and Challenges for Cholera Vaccines in Africa`
A09	`01`	`1`	`ENG`	`@1 Cholera in Africa: Microbiology, Epidemiology, Prevention and Control`
A11	`01`	`1`		`@1 VON SEIDLEIN (Lorenz)`
A11	`02`	`1`		`@1 JIDDAWI (Mohammad)`
A11	`03`	`1`		`@1 GRAIS (Rebecca F.)`
A11	`04`	`1`		`@1 LUQUERO (Francisco)`
A11	`05`	`1`		`@1 LUCAS (Marcelino)`
A11	`06`	`1`		`@1 DEEN (Jacqueline)`
A12	`01`	`1`		`@1 MENGEL (Martin) @9 ed.`
A12	`02`	`1`		`@1 MINTZ (Eric) @9 ed.`
A12	`03`	`1`		`@1 BALAKRISH NAIR (Gopinath) @9 ed.`
A12	`04`	`1`		`@1 GESSNER (Bradford D.) @9 ed.`
A14	`01`			`@1 Menzies School of Health Research @2 Casuarina @3 AUS @Z 1 aut. @Z 6 aut.`
A14	`02`			`@1 Ministry of Health @2 Zanzibar @3 TZA @Z 2 aut.`
A14	`03`			`@1 Epicentre @2 Paris @3 FRA @Z 3 aut. @Z 4 aut.`
A14	`04`			`@1 Ministry of Health @2 Maputo @3 MOZ @Z 5 aut.`
A15	`01`			`@1 Agence de Médecine Préventive @2 Paris @3 FRA @Z 1 aut. @Z 4 aut.`
A15	`02`			`@1 US Centers for Disease control and Prevention @2 Atlanta, Georgia @3 USA @Z 2 aut.`
A15	`03`			`@1 National Institute of Cholera and Enteric Diseases @2 Kolkata @3 IND @Z 3 aut.`
A20				`@2 S8-S14`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 2052 @5 354000504226750020`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 49 ref.`
A47	`01`	`1`		`@0 13-0348253`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 The Journal of infectious diseases`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.
C02	`01`	`X`		`@0 002A05B15`
C02	`02`	`X`		`@0 002B05`
C02	`03`	`X`		`@0 002A05F04`
C03	`01`	`X`	`FRE`	`@0 Vibrio cholerae @2 NS @5 01`
C03	`01`	`X`	`ENG`	`@0 Vibrio cholerae @2 NS @5 01`
C03	`01`	`X`	`SPA`	`@0 Vibrio cholerae @2 NS @5 01`
C03	`02`	`X`	`FRE`	`@0 Vaccin @5 05`
C03	`02`	`X`	`ENG`	`@0 Vaccine @5 05`
C03	`02`	`X`	`SPA`	`@0 Vacuna @5 05`
C03	`03`	`X`	`FRE`	`@0 Afrique @2 NG @5 06`
C03	`03`	`X`	`ENG`	`@0 Africa @2 NG @5 06`
C03	`03`	`X`	`SPA`	`@0 Africa @2 NG @5 06`
C03	`04`	`X`	`FRE`	`@0 Infection @5 07`
C03	`04`	`X`	`ENG`	`@0 Infection @5 07`
C03	`04`	`X`	`SPA`	`@0 Infección @5 07`
C07	`01`	`X`	`FRE`	`@0 Vibrionaceae @2 NS`
C07	`01`	`X`	`ENG`	`@0 Vibrionaceae @2 NS`
C07	`01`	`X`	`SPA`	`@0 Vibrionaceae @2 NS`
C07	`02`	`X`	`FRE`	`@0 Bactérie`
C07	`02`	`X`	`ENG`	`@0 Bacteria`
C07	`02`	`X`	`SPA`	`@0 Bacteria`
N21				`@1 329`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000734

Links to Exploration step

Pascal:13-0348253

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The Value of and Challenges for Cholera Vaccines in Africa</title>
<author><name sortKey="Von Seidlein, Lorenz" sort="Von Seidlein, Lorenz" uniqKey="Von Seidlein L" first="Lorenz" last="Von Seidlein">Lorenz Von Seidlein</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Menzies School of Health Research</s1>
<s2>Casuarina</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Jiddawi, Mohammad" sort="Jiddawi, Mohammad" uniqKey="Jiddawi M" first="Mohammad" last="Jiddawi">Mohammad Jiddawi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Ministry of Health</s1>
<s2>Zanzibar</s2>
<s3>TZA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Tanzanie</country>
</affiliation>
</author>
<author><name sortKey="Grais, Rebecca F" sort="Grais, Rebecca F" uniqKey="Grais R" first="Rebecca F." last="Grais">Rebecca F. Grais</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Epicentre</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Luquero, Francisco" sort="Luquero, Francisco" uniqKey="Luquero F" first="Francisco" last="Luquero">Francisco Luquero</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Epicentre</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Lucas, Marcelino" sort="Lucas, Marcelino" uniqKey="Lucas M" first="Marcelino" last="Lucas">Marcelino Lucas</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Ministry of Health</s1>
<s2>Maputo</s2>
<s3>MOZ</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Mozambique</country>
</affiliation>
</author>
<author><name sortKey="Deen, Jacqueline" sort="Deen, Jacqueline" uniqKey="Deen J" first="Jacqueline" last="Deen">Jacqueline Deen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Menzies School of Health Research</s1>
<s2>Casuarina</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0348253</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0348253 INIST</idno>
<idno type="RBID">Pascal:13-0348253</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000734</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005756</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The Value of and Challenges for Cholera Vaccines in Africa</title>
<author><name sortKey="Von Seidlein, Lorenz" sort="Von Seidlein, Lorenz" uniqKey="Von Seidlein L" first="Lorenz" last="Von Seidlein">Lorenz Von Seidlein</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Menzies School of Health Research</s1>
<s2>Casuarina</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Jiddawi, Mohammad" sort="Jiddawi, Mohammad" uniqKey="Jiddawi M" first="Mohammad" last="Jiddawi">Mohammad Jiddawi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Ministry of Health</s1>
<s2>Zanzibar</s2>
<s3>TZA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Tanzanie</country>
</affiliation>
</author>
<author><name sortKey="Grais, Rebecca F" sort="Grais, Rebecca F" uniqKey="Grais R" first="Rebecca F." last="Grais">Rebecca F. Grais</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Epicentre</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Luquero, Francisco" sort="Luquero, Francisco" uniqKey="Luquero F" first="Francisco" last="Luquero">Francisco Luquero</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Epicentre</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Lucas, Marcelino" sort="Lucas, Marcelino" uniqKey="Lucas M" first="Marcelino" last="Lucas">Marcelino Lucas</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Ministry of Health</s1>
<s2>Maputo</s2>
<s3>MOZ</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Mozambique</country>
</affiliation>
</author>
<author><name sortKey="Deen, Jacqueline" sort="Deen, Jacqueline" uniqKey="Deen J" first="Jacqueline" last="Deen">Jacqueline Deen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Menzies School of Health Research</s1>
<s2>Casuarina</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">The Journal of infectious diseases</title>
<title level="j" type="abbreviated">J. infect. dis.</title>
<idno type="ISSN">0022-1899</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">The Journal of infectious diseases</title>
<title level="j" type="abbreviated">J. infect. dis.</title>
<idno type="ISSN">0022-1899</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa</term>
<term>Infection</term>
<term>Vaccine</term>
<term>Vibrio cholerae</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Vibrio cholerae</term>
<term>Vaccin</term>
<term>Afrique</term>
<term>Infection</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-1899</s0>
</fA01>
<fA02 i1="01"><s0>JIDIAQ</s0>
</fA02>
<fA03 i2="1"><s0>J. infect. dis.</s0>
</fA03>
<fA05><s2>208</s2>
</fA05>
<fA06><s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>The Value of and Challenges for Cholera Vaccines in Africa</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Cholera in Africa: Microbiology, Epidemiology, Prevention and Control</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>VON SEIDLEIN (Lorenz)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JIDDAWI (Mohammad)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GRAIS (Rebecca F.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>LUQUERO (Francisco)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LUCAS (Marcelino)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>DEEN (Jacqueline)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>MENGEL (Martin)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>MINTZ (Eric)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>BALAKRISH NAIR (Gopinath)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>GESSNER (Bradford D.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Menzies School of Health Research</s1>
<s2>Casuarina</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Ministry of Health</s1>
<s2>Zanzibar</s2>
<s3>TZA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Epicentre</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Ministry of Health</s1>
<s2>Maputo</s2>
<s3>MOZ</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Agence de Médecine Préventive</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>US Centers for Disease control and Prevention</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>National Institute of Cholera and Enteric Diseases</s1>
<s2>Kolkata</s2>
<s3>IND</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA20><s2>S8-S14</s2>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>2052</s2>
<s5>354000504226750020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>49 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0348253</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>The Journal of infectious diseases</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on providing safe drinking water and improving sanitation and hygiene has proven remarkably insufficient to contain outbreaks. Current killed whole-cell oral cholera vaccines (OCVs) are safe and guarantee a high level of protection for several years. OCVs have been licensed for >20 years, but their potential for preventing and control cholera outbreaks in Africa has not been realized. Although each item in the long list of technical reasons why cholera vaccination campaigns have been deferred is plausible, we believe that the biggest barrier is that populations affected by cholera outbreaks are underprivileged and lack a strong political voice. The evaluation and use of OCVs as a tool for cholera control will require a new, more compassionate, less risk-averse generation of decision makers.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05B15</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002A05F04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Vibrio cholerae</s0>
<s2>NS</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Vibrio cholerae</s0>
<s2>NS</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Vibrio cholerae</s0>
<s2>NS</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Vaccin</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Vaccine</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Vacuna</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Infection</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Infection</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Infección</s0>
<s5>07</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Vibrionaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Vibrionaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Vibrionaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fN21><s1>329</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005756 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 005756 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:13-0348253
   |texte=   The Value of and Challenges for Cholera Vaccines in Africa
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

The Value of and Challenges for Cholera Vaccines in Africa

The Value of and Challenges for Cholera Vaccines in Africa

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri